Latest News and Press Releases
Want to stay updated on the latest news?
-
Bloomingdale, Illinois, Feb. 13, 2021 (GLOBE NEWSWIRE) -- Every February Americans observe American Heart Month to raise awareness and reaffirm the importance of a healthy heart. Heart disease...
-
36% ORR and 64% DCR (RECIST 1.1)PV-10-induced, tumor-specific restoration of T cell functionData compare favorably to approved and investigational therapies for patient population KNOXVILLE, TN,...
-
62% 2-year OS; median OS not reachedStable, non-overlapping safety profileClinical synergy between PV-10 and immune checkpoint blockadeData compare favorably to approved therapies for patient...
-
MINNEAPOLIS, Sept. 10, 2020 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV) an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for...
-
Cranbury, NJ, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, announced today that...
-
Atlanta, GA, Oct. 02, 2019 (GLOBE NEWSWIRE) -- This week’s news that the National Institutes of Health (NIH) has awarded two Georgia universities major grants to advance work toward a universal flu...
-
Vail, Colorado, Aug. 22, 2019 (GLOBE NEWSWIRE) -- The National Institutes of Health (NIH) awarded Steadman Philippon Research Institute (SPRI) a grant to study muscle-derived stem cells (MDSCs)...
-
Vail, Colorado, Aug. 20, 2019 (GLOBE NEWSWIRE) -- The National Institutes of Health (NIH) has awarded Steadman Philippon Research Institute (SPRI) a grant to study the correlation between...
-
Vail, Colorado, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Steadman Philippon Research Institute (SPRI) has received a research award from the National Institutes of Health (NIH) to investigate bone...
-
Company has received NIH federal grant of approximately $223,000Anticipates additional federal grant of approximately $1.0 millionWomen’s health initiative to focus on potential HPV related onco-virus...